Proteome database of hepatocellular carcinoma

Area of Science:

• Oncology
• Proteomics
• Hepatology

Background:

• Hepatocellular carcinoma (HCC), or hepatoma, is the most prevalent primary liver cancer globally.
• Persistent hepatitis B or C viral infections are major causes of HCC, leading to approximately one million deaths annually, with increasing incidence in developed nations.
• Late presentation and unsuitability for curative treatment result in rare long-term survival for most HCC patients.

Purpose of the Study:

• To identify novel diagnostic markers for early HCC detection.
• To discover tumor-specific associated proteins as potential therapeutic targets for HCC treatment.
• To facilitate the screening and discovery of HCC proteins through proteome analysis.

Main Methods:

• Proteome analysis of HCC cell lines and liver tumor tissues.
• Development and updating of a two-dimensional electrophoresis proteome database.
• Making the HCC-M cell line proteome database accessible via the World Wide Web.

Main Results:

• An updated two-dimensional electrophoresis proteome database for the HCC-M cell line has been generated.
• The HCC-M proteome database is now publicly accessible online.
• This resource supports the ongoing search for HCC diagnostic and therapeutic targets.

Conclusions:

• Proteome databases are crucial for identifying novel HCC biomarkers and therapeutic targets.
• Accessible proteomic data accelerates research into early detection and treatment of hepatocellular carcinoma.
• The HCC-M proteome database provides a valuable resource for the scientific community studying liver cancer.